Skip to main content

Article Category

News

Article available in the folowing languages:

Biotech Patenting Conference

Monday 1st and Tuesday 2nd March 2004,Post-Conference Workshop - Wednesday 3rd March 2004,Forum Hotel, Munich, Germany

View the agenda and register online at: http://www.euro-legal.co.uk/biopatenting/pr The past year has been a landmark one for the biotech industry. There have been important decisions in the US and Europe, which will affect the value of biotechnology patents and the way patents, are sought in the future. EuroLegals Biotech Patenting conference is specifically designed to give you the up-to-the minute information you need to stay ahead. We have assembled a faculty of leading in-house biotech and pharmaceutical counsel, patent attorneys and a representative from the EPO, they will give you the very latest information and advice which will translate into commercial gain for your company. Get important insights from biotech industry leaders including Vertex Pharmaceuticals Incorporated (USA), Geron Corporation (USA), Bayer AG (Germany), Oxford GlycoSciences (UK) Ltd, MediGene AG (Germany), NovoZymes AS (Denmark), MorphoSys AG (Germany), Biovitrum AS (Sweden), Orion Corporation Orion Pharma (Finland). For further information please contact:,James Stackhouse on Tel: +44 (0) 20 7878 6929,Or e-mail: james@ef-international.co.uk,http://www.euro-legal.co.uk/biopatenting ,

Countries

Germany